Stroke risk in hypertensive patients with coronary artery disease (CAD): The International Verapamil SR-trandolapril Study (INVEST)

被引：0
|
作者：
Pepine, C [1 ]
Coca, A [1 ]
Messerli, F [1 ]
Benetos, A [1 ]
Zhou, Q [1 ]
Champion, A [1 ]
Cooper-DeHoff, R [1 ]
机构：
[1] Univ Florida, Coll Med, Gainesville, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：424A / 424A
页数：1
相关论文
共 50 条
  • [21] Global differences in blood pressure control, findings from the international verapamil SR-trandolapril study (INVEST)
    Mancia, G
    Zineh, I
    Cooper-DeHoff, R
    Zhou, Q
    Champion, A
    Pepine, C
    JOURNAL OF HYPERTENSION, 2005, 23 : S114 - S114
  • [22] Association of "J-Shaped" Curves and Age: A Substudy of the International Verapamil SR-Trandolapril Study (INVEST)
    Denardo, Scott J.
    Messerli, Franz H.
    Aranda, Juan M., Jr.
    Cooper-DeHoff, Rhonda M.
    Handberg, Eileen M.
    Gong, Yan
    Champion, Annette
    Pepine, Carl J.
    CIRCULATION, 2008, 118 (18) : S1160 - S1160
  • [23] Blood pressure <120/80 mm hg is risky in elderly CAD patients:: Findings from the INternational VErapamil SR-trandolapril STudy (INVEST)
    Cooper-Dehoff, Rhonda M.
    Gerhard, Tobias
    Gong, Yan
    Handberg, Eileen M.
    Messerli, Franz H.
    Pepine, Carl J.
    CIRCULATION, 2007, 115 (08) : E258 - E258
  • [24] All-cause mortality and cardioprotection: Equivalent efficacy of a verapamil-SR strategy compared with an atenolol strategy in hypertensive patients with CAD: The INternational VErapamil SR-trandolapril STudy
    Messerli, FH
    Kowey, PR
    Hewkin, AC
    Kupfer, SR
    Pepine, CJ
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 191A - 191A
  • [25] Do hypertensive women with coronary artery disease benefit from lowering systolic blood pressure under 130 mmHg? Long-term mortality in the INternational VErapamil SR-trandolapril STudy (INVEST)
    Sava, R. I.
    Chen, Y.
    Taha, Y. K.
    Gong, Y.
    Smith, S. M.
    Cooper-Dehoff, R.
    Keeley, E. C.
    Pepine, C. J.
    Handberg, E. M.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3598 - 3598
  • [26] Rationale and design of the international verapamil SR Trandolapril study (INVEST): An Internet-based randomized trial in coronary artery disease patients with hypertension
    Pepine, CJ
    Handberg-Thurmond, E
    Marks, RG
    Conlon, M
    Cooper-DeHoff, R
    Volkers, P
    Zellig, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) : 1228 - 1237
  • [27] Increased pulse pressure is strongly associated with adverse cardiovascular outcomes: The International Verapamil SR-Trandolapril Study (INVEST)
    Messerli, FH
    Franklin, S
    Marcia, G
    Hewkin, A
    Kupfer, S
    Labs, A
    Park, A
    Pepine, CJ
    CIRCULATION, 2004, 110 (17) : 682 - 682
  • [28] Incidence of MI is equivalent with verapamil SR-based and atenolol-based strategies in patients with hypertension and CAD: The INternational VErapamil SR-trandolapril STudy
    Cohen, JD
    Kowey, PR
    Sleight, P
    Hewkin, AC
    Handberg, EM
    Kupfer, SR
    Pepine, CJ
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 189A - 189A
  • [29] Clinical outcomes in the diabetes cohort of the international verapamil SR-Trandolapril study
    Bakris, GL
    Gaxiola, E
    Messerli, FH
    Mancia, G
    Erdine, S
    Cooper-DeHoff, R
    Pepine, CJ
    HYPERTENSION, 2004, 44 (05) : 637 - 642
  • [30] CXCL5 gene polymorphism and major cardiovascular events in the international verapamil SR-trandolapril study (INVEST)
    Zineh, I.
    Beitelshees, A. L.
    Langaee, T. Y.
    Cooper-Dehoff, R. M.
    Pepine, C. J.
    Johnson, J. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 334 - 334
12345